Menu

• Ask a Health Expert about THROMBOLYSIS
• Post Your Side Effect related to THROMBOLYSIS
• THROMBOLYSIS and FDA Warnings
• THROMBOLYSIS in Patients Wiki
• Report THROMBOLYSIS in Drug Side Effect Survey

THROMBOLYSIS side effect

What is THROMBOLYSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Arixtra Side Effects Report #5498509-5
Physician from UNITED STATES reported ARIXTRA problem on Oct 25, 2007. Male patient, weighting 163.1 lb, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: thrombolysis, . ARIXTRA dosage: unknown. Patient was hospitalized. Patient recovered.

Champix Side Effects Report #5493904-2
CHAMPIX problem was reported by a Health Professional from UNITED KINGDOM on Oct 11, 2007. Female patient, 70 years of age, weighting 176.4 lb, was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, thrombolysis, . CHAMPIX dosage: unknown. During the same period patient was treated with ADIZEM, ACETYLSALICYLIC ACID SRT, BECLOMETHASONE DIPROPIONATE, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Champix Side Effects Report #5449397-4
Health Professional from UNITED KINGDOM reported CHAMPIX problem on Aug 30, 2007. Female patient, 70 years of age, weighting 176.4 lb, was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, thrombolysis, . CHAMPIX dosage: unknown. During the same period patient was treated with ADIZEM, ASPIRIN, BECLOMETHASONE DIPROPIONATE, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Cafergot Side Effects Report #5405858-5
CAFERGOT problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 01, 2007. Female patient, 73 years of age, weighting 105.8 lb, was diagnosed with migraine, transient ischaemic attack, nausea, gastritis, asthma and was treated with CAFERGOT. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, thrombolysis, . CAFERGOT dosage: unknown. During the same period patient was treated with ASPIRIN, DOMPERIDONE, LANSOPRAZOLE, SERETIDE, SUMATRIPTAN. Patient was hospitalized. Patient recovered.


Sumatriptan Side Effects Report #5416739-5
Consumer or non-health professional from UNITED KINGDOM reported SUMATRIPTAN SUCCINATE problem on Aug 06, 2007. Female patient, 73 years of age, weighting 105.8 lb, was diagnosed with migraine, nausea, gastritis, asthma and was treated with SUMATRIPTAN SUCCINATE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, thrombolysis, . SUMATRIPTAN SUCCINATE dosage: unknown. During the same period patient was treated with CAFERGOT, ASPIRIN, DOMPERIDONE, LANSOPRAZOLE, SERETIDE. Patient was hospitalized. Patient recovered.

Chantix Side Effects Report #5756187-1
CHANTIX problem was reported by a Health Professional from UNITED KINGDOM on May 21, 2008. Female patient, 70 years of age, weighting 176.4 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, thrombolysis, . CHANTIX dosage: unknown. During the same period patient was treated with ADIZEM, ACETYLSALICYLIC ACID SRT, BECLOMETHASONE DIPROPIONATE, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Aspirin Side Effects Report #5271886-6
Consumer or non-health professional from UNITED KINGDOM reported ASPIRIN problem on Mar 05, 2007. Male patient, 70 years of age, weighting 132.3 lb, was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, thrombolysis, . ASPIRIN dosage: 300 MG, ORAL. During the same period patient was treated with CLOPIDOGREL, ENOXAPARIN, TENECTEPLASE, ATENOLOL, MORPHINE. Patient died on 10/03/2006.